FDA Inspection
Algunas Inc., dba Woodland Hills Compounding PharmacyAlgunas Inc., dba Woodland Hills Compounding Pharmacy – FDA Inspection, Apr 29, 2016
Record Details
This FDA Inspection record concerns Algunas Inc., dba Woodland Hills Compounding Pharmacy, with an inspection on April 29, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 29, 2016
- Product Type
- Drugs
View Company Profile
ID · 044dd8e7-d705-4b39-95dc-ea39131d120d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 971393
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Algunas Inc., dba Woodland Hills Compounding Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Algunas Inc., dba Woodland Hills Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.